These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 24637058)

  • 1. The association of left ventricular lead position related to regional scar by speckle-tracking echocardiography with clinical outcomes in patients receiving cardiac resynchronization therapy.
    Sade LE; Saba S; Marek JJ; Onishi T; Schwartzman D; Adelstein EC; Soman P; Gorcsan J
    J Am Soc Echocardiogr; 2014 Jun; 27(6):648-56. PubMed ID: 24637058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial.
    Khan FZ; Virdee MS; Palmer CR; Pugh PJ; O'Halloran D; Elsik M; Read PA; Begley D; Fynn SP; Dutka DP
    J Am Coll Cardiol; 2012 Apr; 59(17):1509-18. PubMed ID: 22405632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic benefit of optimum left ventricular lead position in cardiac resynchronization therapy: follow-up of the TARGET Study Cohort (Targeted Left Ventricular Lead Placement to guide Cardiac Resynchronization Therapy).
    Kydd AC; Khan FZ; Watson WD; Pugh PJ; Virdee MS; Dutka DP
    JACC Heart Fail; 2014 Jun; 2(3):205-12. PubMed ID: 24952685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left ventricular lead position, mechanical activation, and myocardial scar in relation to left ventricular reverse remodeling and clinical outcomes after cardiac resynchronization therapy: A feature-tracking and contrast-enhanced cardiovascular magnetic resonance study.
    Taylor RJ; Umar F; Panting JR; Stegemann B; Leyva F
    Heart Rhythm; 2016 Feb; 13(2):481-9. PubMed ID: 26498258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Echocardiography-guided left ventricular lead placement for cardiac resynchronization therapy: results of the Speckle Tracking Assisted Resynchronization Therapy for Electrode Region trial.
    Saba S; Marek J; Schwartzman D; Jain S; Adelstein E; White P; Oyenuga OA; Onishi T; Soman P; Gorcsan J
    Circ Heart Fail; 2013 May; 6(3):427-34. PubMed ID: 23476053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dependency of cardiac resynchronization therapy on myocardial viability at the LV lead position.
    Becker M; Zwicker C; Kaminski M; Napp A; Altiok E; Ocklenburg C; Friedman Z; Adam D; Schauerte P; Marx N; Hoffmann R
    JACC Cardiovasc Imaging; 2011 Apr; 4(4):366-74. PubMed ID: 21492811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left Ventricular Lead Position Guided by Parametric Strain Echocardiography Improves Response to Cardiac Resynchronization Therapy.
    Mele D; Nardozza M; Malagù M; Leonetti E; Fragale C; Rondinella A; Ferrari R; Bertini M
    J Am Soc Echocardiogr; 2017 Oct; 30(10):1001-1011. PubMed ID: 28822669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison between radial strain evaluation by speckle-tracking echocardiography and cardiac magnetic resonance imaging, for assessment of suitable segments for left ventricular lead placement in cardiac resynchronization therapy.
    Bakos Z; Ostenfeld E; Markstad H; Werther-Evaldsson A; Roijer A; Arheden H; Carlsson M; Borgquist R
    Europace; 2014 Dec; 16(12):1779-86. PubMed ID: 25031235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular regional remodeling and lead position during cardiac resynchronization therapy.
    Kronborg MB; Sommer A; Fyenbo DB; Norgaard BL; Gerdes C; Jensen JM; Jensen HK; Kristensen J; Nielsen JC
    Heart Rhythm; 2018 Oct; 15(10):1542-1549. PubMed ID: 29678780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal left ventricular lead position predicts reverse remodeling and survival after cardiac resynchronization therapy.
    Ypenburg C; van Bommel RJ; Delgado V; Mollema SA; Bleeker GB; Boersma E; Schalij MJ; Bax JJ
    J Am Coll Cardiol; 2008 Oct; 52(17):1402-9. PubMed ID: 18940531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodality imaging-guided left ventricular lead placement in cardiac resynchronization therapy: a randomized controlled trial.
    Sommer A; Kronborg MB; Nørgaard BL; Poulsen SH; Bouchelouche K; Böttcher M; Jensen HK; Jensen JM; Kristensen J; Gerdes C; Mortensen PT; Nielsen JC
    Eur J Heart Fail; 2016 Nov; 18(11):1365-1374. PubMed ID: 27087019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of left ventricular lead position relative to scar location on response to cardiac resynchronization therapy: a model study.
    Huntjens PR; Walmsley J; Ploux S; Bordachar P; Prinzen FW; Delhaas T; Lumens J
    Europace; 2014 Nov; 16 Suppl 4():iv62-iv68. PubMed ID: 25362172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of myocardial viability and left ventricular lead location on clinical outcome in cardiac resynchronization therapy recipients with ischemic cardiomyopathy.
    Bose A; Kandala J; Upadhyay GA; Riedl L; Ahmado I; Padmanabhan R; Gewirtz H; Mulligan LJ; Singh JP
    J Cardiovasc Electrophysiol; 2014 May; 25(5):507-513. PubMed ID: 24350650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of speckle tracking echocardiography to characterize dysfunctional myocardium in patients with ischemic cardiomyopathy referred for cardiac resynchronization therapy.
    Kydd AC; Khan F; Gopalan D; Ring L; Rana BS; Virdee MS; Dutka DP
    Echocardiography; 2014 Jul; 31(6):736-43. PubMed ID: 24303794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scar burden by myocardial perfusion imaging predicts echocardiographic response to cardiac resynchronization therapy in ischemic cardiomyopathy.
    Adelstein EC; Saba S
    Am Heart J; 2007 Jan; 153(1):105-12. PubMed ID: 17174647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of echocardiographically guided left ventricular lead placement for cardiac resynchronization therapy in patients with intermediate QRS width and non-left bundle branch block morphology.
    Marek JJ; Saba S; Onishi T; Ryo K; Schwartzman D; Adelstein EC; Gorcsan J
    Am J Cardiol; 2014 Jan; 113(1):107-16. PubMed ID: 24169014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular scar impact on left ventricular synchronization parameters and outcomes of cardiac resynchronization therapy.
    Ahmed W; Samy W; Tayeh O; Behairy N; Abd El Fattah A
    Int J Cardiol; 2016 Nov; 222():665-670. PubMed ID: 27517660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longer inter-lead electrical delay is associated with response to cardiac resynchronization therapy in patients with presumed optimal left ventricular lead position.
    Sommer A; Kronborg MB; Nørgaard BL; Stephansen C; Poulsen SH; Kristensen J; Gerdes C; Nielsen JC
    Europace; 2018 Oct; 20(10):1630-1637. PubMed ID: 29377984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pacing transmural scar tissue reduces left ventricle reverse remodeling after cardiac resynchronization therapy.
    Mele D; Agricola E; Monte AD; Galderisi M; D'Andrea A; Rigo F; Citro R; Chiodi E; Marchese G; Valentina PD; Calabrese A; Ferrari R
    Int J Cardiol; 2013 Jul; 167(1):94-101. PubMed ID: 22225709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of left ventricular lead position on left ventricular reverse remodelling and improvement in mechanical dyssynchrony in cardiac resynchronization therapy.
    Kristiansen HM; Vollan G; Hovstad T; Keilegavlen H; Faerestrand S
    Eur Heart J Cardiovasc Imaging; 2012 Dec; 13(12):991-1000. PubMed ID: 22677455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.